deltatrials

Acute respiratory distress syndrome Trials in Seattle, United States

Conditions / Acute respiratory distress syndrome / Seattle, United States

Acute respiratory distress syndrome is a medical condition with active clinical research programs worldwide.

17 total trials for this combination

Showing top 10 of 17 trials

Trials

NCT ID Title Status Phase
NCT02509078 Reevaluation Of Systemic Early Neuromuscular Blockade COMPLETED PHASE3
NCT04291508 Acetaminophen and Ascorbate in Sepsis: Targeted Therapy to Enhance Recovery COMPLETED PHASE2
NCT06703073 JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS (Master Record) RECRUITING PHASE2
NCT04537806 A Study of Brexanolone for Acute Respiratory Distress Syndrome (ARDS) Due to Coronavirus Disease 2019 (COVID-19) TERMINATED PHASE3
NCT06701682 JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort A: Vilobelimab RECRUITING PHASE2
NCT05388708 ARDS in Children and ECMO Initiation Strategies Impact on Neurodevelopment (ASCEND) RECRUITING
NCT03021824 Severe ARDS: Generating Evidence COMPLETED
NCT03096314 Vitamin D to Improve Outcomes by Leveraging Early Treatment COMPLETED PHASE3
NCT06701669 JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort B: Paridiprubart RECRUITING PHASE2
NCT06066502 Precision Ventilation vs Standard Care for Acute Respiratory Distress Syndrome RECRUITING PHASE3

Related Pages